Russo Rene

Russo Rene is listed in filings as PRESIDENT AND CEO at Xilio Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 5, 2026, including purchase activity. Recent filings connect the profile to Xilio Therapeutics, Inc. (XLO). The current snapshot covers public activity from Jan 3, 2025 to Jan 5, 2026. Reported amounts are shown as $609.3K to $24.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.